European Austerity Drama May Likely Spur The Pace But Not Change The Strategic Plot Line For Pharma

Price cuts and austerity measures made 2011 a bleak year for European pharma. These dynamics are more severe but not new, and likely will accelerate firms’ existing geographic expansion and market access strategies.